Sifting through the surfeit of neuroinflammation tracers
The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) rev...
Saved in:
Published in | Journal of cerebral blood flow and metabolism Vol. 38; no. 2; pp. 204 - 224 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.02.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-(R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers. |
---|---|
AbstractList | The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [
C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [
C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers. The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [ 11 C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers. The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-( R )-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [ 11 C]-( R )-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers. The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers.The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-( R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-( R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers. The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(R)-PK11195, the prototype isoquinoline ligand for translocator protein (18 kDa) (TSPO). Investigations by positron emission tomography (PET) revealed microgliosis in numerous brain diseases, despite the rather low specific binding signal imparted by [11C]-(R)-PK11195. There has since been enormous expansion of the repertoire of TSPO tracers, many with higher specific binding, albeit complicated by allelic dependence of the affinity. However, the specificity of TSPO PET for revealing microglial activation not been fully established, and it has been difficult to judge the relative merits of the competing tracers and analysis methods with respect to their sensitivity for detecting microglial activation. We therefore present a systematic comparison of 13 TSPO PET and single photon computed tomography (SPECT) tracers belonging to five structural classes, each of which has been investigated by compartmental analysis in healthy human brain relative to a metabolite-corrected arterial input. We emphasize the need to establish the non-displaceable binding component for each ligand and conclude with five recommendations for a standard approach to define the cellular distribution of TSPO signals, and to characterize the properties of candidate TSPO tracers. |
Author | Patkar, Omkar Banati, Richard Vasdev, Neil Thomas, Paul Breakspear, Michael Liu, Guo-Jun Burgher, Bjorn Cumming, Paul |
AuthorAffiliation | 1 School of Psychology and Counselling and IHBI, Faculty of Health, Queensland University of Technology, Brisbane, Australia 3 Metro North Mental Health Service, Brisbane, Australia 4 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA, USA 8 National Imaging Facility, Brain and Mind Centre and Faculty of Health Sciences, University of Sydney, Camperdown, Australia 5 Department of Radiology, Harvard Medical School, Boston, MA, USA 2 56362 QIMR Berghofer Institute , Brisbane, Australia 7 5419 Australian Nuclear Science and Technology Organisation , Lucas Heights, Australia 6 Herston Imaging Research Facility, Faculty of Medicine, 303224 University of Queensland Centre for Clinical Research , Herston, Australia |
AuthorAffiliation_xml | – name: 2 56362 QIMR Berghofer Institute , Brisbane, Australia – name: 7 5419 Australian Nuclear Science and Technology Organisation , Lucas Heights, Australia – name: 5 Department of Radiology, Harvard Medical School, Boston, MA, USA – name: 4 Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Boston, MA, USA – name: 6 Herston Imaging Research Facility, Faculty of Medicine, 303224 University of Queensland Centre for Clinical Research , Herston, Australia – name: 8 National Imaging Facility, Brain and Mind Centre and Faculty of Health Sciences, University of Sydney, Camperdown, Australia – name: 1 School of Psychology and Counselling and IHBI, Faculty of Health, Queensland University of Technology, Brisbane, Australia – name: 3 Metro North Mental Health Service, Brisbane, Australia |
Author_xml | – sequence: 1 givenname: Paul surname: Cumming fullname: Cumming, Paul email: paul.cumming@qut.edu.au – sequence: 2 givenname: Bjorn surname: Burgher fullname: Burgher, Bjorn – sequence: 3 givenname: Omkar surname: Patkar fullname: Patkar, Omkar – sequence: 4 givenname: Michael surname: Breakspear fullname: Breakspear, Michael – sequence: 5 givenname: Neil surname: Vasdev fullname: Vasdev, Neil – sequence: 6 givenname: Paul surname: Thomas fullname: Thomas, Paul – sequence: 7 givenname: Guo-Jun surname: Liu fullname: Liu, Guo-Jun – sequence: 8 givenname: Richard surname: Banati fullname: Banati, Richard |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29256293$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UUtLxDAQDqLornr3JD16qebRJM1FEPEFCx5U8BbSNNmNtIkmreC_N-u6ooKeZuB7Dd9MwaYP3gBwgOAxQpyfQMwR4_Vj3qua12wDTBClouQQsU0wWcLlEt8B05SeIIQ1oXQb7GCBKcOCTEB95-zg_LwYFjGM80WepkhjtMYNRbCFN2MMzttO9b0aXPDFEJU2Me2BLau6ZPY_5y54uLy4P78uZ7dXN-dns1JTCIdS26ahTctULYiuSCsqW1uNKkEpIy0TTdtAiC0hbUU4E1wZpAkzuG2FwMgIsgtOV77PY9ObVhufD-jkc3S9im8yKCd_It4t5Dy8Sioogphkg6NPgxheRpMG2bukTdcpb8KYJBK85gRTWGXq4fesr5B1XZnAVgQdQ0rRWKnd8FFLjnadRFAu_yJ__yUL4S_h2vsfSbmSJDU38imM0eee_-a_A0A2nOQ |
CitedBy_id | crossref_primary_10_1038_s41380_023_02188_8 crossref_primary_10_1186_s12974_023_02769_y crossref_primary_10_1210_clinem_dgab797 crossref_primary_10_2967_jnumed_119_237735 crossref_primary_10_3390_molecules29245936 crossref_primary_10_1016_j_apsb_2020_08_006 crossref_primary_10_1177_0271678X21992457 crossref_primary_10_1186_s40658_021_00381_8 crossref_primary_10_1016_j_yexmp_2019_03_008 crossref_primary_10_1126_sciadv_adi8986 crossref_primary_10_1016_j_cpet_2018_12_010 crossref_primary_10_1016_j_neulet_2020_134938 crossref_primary_10_1161_STROKEAHA_122_036946 crossref_primary_10_1007_s11307_020_01575_9 crossref_primary_10_3390_cimb45110539 crossref_primary_10_1111_jnc_15615 crossref_primary_10_1002_mds_27620 crossref_primary_10_1007_s00259_019_04349_w crossref_primary_10_1186_s13550_021_00786_7 crossref_primary_10_2214_AJR_21_26159 crossref_primary_10_1016_j_jneuroim_2024_578468 crossref_primary_10_1007_s00259_021_05495_w crossref_primary_10_1186_s12974_018_1352_9 crossref_primary_10_62347_AICM8774 crossref_primary_10_1007_s00259_019_04294_8 crossref_primary_10_3390_ijms22115606 crossref_primary_10_1007_s00259_019_04403_7 crossref_primary_10_1016_j_biopsych_2018_02_1171 crossref_primary_10_1002_mds_28825 crossref_primary_10_1093_braincomms_fcac019 crossref_primary_10_1097_j_pain_0000000000003247 crossref_primary_10_3390_biom13020290 crossref_primary_10_1007_s00259_021_05425_w crossref_primary_10_1007_s00259_020_04810_1 crossref_primary_10_1002_cmdc_201900608 crossref_primary_10_1007_s11307_021_01646_5 crossref_primary_10_1017_S0033291718003057 crossref_primary_10_1186_s12974_018_1347_6 crossref_primary_10_1177_0271678X20951995 crossref_primary_10_1016_j_bbi_2023_07_023 crossref_primary_10_1111_ejn_15613 crossref_primary_10_1111_epi_15967 crossref_primary_10_1038_s42003_022_04214_x crossref_primary_10_1002_ddr_21547 crossref_primary_10_1038_s41380_020_0745_1 crossref_primary_10_1177_0271678X19858003 crossref_primary_10_1002_tcr_202300072 crossref_primary_10_3390_biomedicines10010034 crossref_primary_10_1093_brain_awy188 crossref_primary_10_1007_s00259_019_4268_4 crossref_primary_10_1186_s12974_020_02046_2 crossref_primary_10_3389_fimmu_2022_1010263 crossref_primary_10_1093_brain_awab127 crossref_primary_10_1177_0271678X241240843 crossref_primary_10_1007_s00247_021_05248_9 crossref_primary_10_1016_j_bmcl_2019_06_037 crossref_primary_10_1007_s00259_020_04885_w crossref_primary_10_1007_s00259_021_05248_9 crossref_primary_10_1016_j_nbd_2022_105700 crossref_primary_10_1017_pen_2020_14 crossref_primary_10_1212_NXI_0000000000000984 crossref_primary_10_1097_RLU_0000000000004803 crossref_primary_10_1007_s00259_020_04844_5 crossref_primary_10_1016_j_cpet_2020_12_003 crossref_primary_10_1016_j_phrs_2023_106681 crossref_primary_10_1186_s12974_024_03080_0 crossref_primary_10_1016_j_pharmthera_2018_09_003 crossref_primary_10_23736_S1824_4785_22_03465_3 crossref_primary_10_1016_j_neuroimage_2020_117707 crossref_primary_10_1007_s00259_021_05398_w crossref_primary_10_3389_fnmol_2022_981442 crossref_primary_10_1098_rsob_210173 crossref_primary_10_1177_1536012118792317 crossref_primary_10_1080_10253890_2022_2045269 crossref_primary_10_1016_j_drudis_2021_09_021 crossref_primary_10_1021_acs_jmedchem_1c00379 crossref_primary_10_1007_s00259_020_04732_y crossref_primary_10_3389_fcell_2021_715444 crossref_primary_10_3390_cells12172128 crossref_primary_10_1016_j_tips_2019_11_005 crossref_primary_10_1021_acschemneuro_0c00802 crossref_primary_10_1111_epi_18351 crossref_primary_10_1016_j_bbr_2020_113004 crossref_primary_10_1016_j_expneurol_2024_114843 crossref_primary_10_3390_cells9020512 |
Cites_doi | 10.1016/S0031-6997(24)01424-8 10.1210/en.2015-1795 10.1038/jcbfm.2012.59 10.1016/j.bmcl.2011.12.084 10.1126/science.1248725 10.1073/pnas.81.3.753 10.1073/pnas.1511003112 10.1038/jcbfm.2014.261 10.1126/science.1260590 10.1038/jcbfm.1993.6 10.1016/S0304-3835(00)00451-1 10.1080/13550280500187351 10.1023/A:1018567510105 10.1001/jamaneurol.2016.3764 10.1074/jbc.M114.578286 10.1177/0271678X16646788 10.1523/JNEUROSCI.1487-12.2012 10.1038/nri2550 10.1124/dmd.112.046342 10.1073/pnas.94.10.5101 10.1093/pcp/pch088 10.1016/j.pharmthera.2007.12.004 10.1016/j.bbi.2016.01.019 10.1093/brain/124.10.2014 10.1212/01.WNL.0000078192.95645.E6 10.1093/brain/123.11.2321 10.1016/S0026-895X(25)09743-3 10.1210/en.2013-1556 10.1016/S0014-2999(99)00118-1 10.2967/jnumed.117.195396 10.1007/s00259-012-2163-3 10.3389/fnagi.2017.00008 10.1074/jbc.M115.686360 10.1007/s00259-014-2955-8 10.1038/jcbfm.2011.147 10.2967/jnumed.116.178335 10.1176/appi.ajp.2016.15111417 10.1124/jpet.116.238568 10.1038/tp.2016.40 10.1016/S0021-9258(18)77217-7 10.1210/endo.139.12.6390 10.1016/0006-2952(96)00034-2 10.1007/s00259-015-3149-8 10.1016/0014-2999(81)90405-2 10.2967/jnumed.116.178996 10.2967/jnumed.110.077040 10.1016/j.bpj.2011.04.017 10.1016/S0960-894X(02)00886-7 10.1016/0024-3205(83)90062-0 10.1016/S0026-895X(25)10080-1 10.1073/pnas.74.9.3805 10.2967/jnumed.109.062265 10.1097/NEN.0b013e318188b204 10.1002/1097-0142(19900101)65:1<93::AID-CNCR2820650120>3.0.CO;2-1 10.1212/WNL.55.7.1052 10.1007/s00259-016-3444-z 10.1016/j.nucmedbio.2007.12.009 10.1001/jamaneurol.2015.0941 10.1023/A:1005933226966 10.1016/j.nucmedbio.2014.11.003 10.1038/sj.jcbfm.9600340 10.1016/S0378-4347(99)00439-9 10.1021/cn500138n 10.1016/j.neubiorev.2010.10.001 10.1016/S0928-4257(02)00018-9 10.1038/ncomms6452 10.1038/jcbfm.2014.55 10.1016/j.neuroimage.2009.11.056 10.1007/s10048-014-0409-x 10.1016/S1474-4422(15)70016-5 10.1093/ijnp/pyw077 10.1007/s00259-007-0645-5 10.1177/0271678X17699223 10.1080/15384101.2017.1281477 10.1016/S0021-9258(18)92812-7 10.1016/0024-3205(93)90293-C 10.1001/jamapsychiatry.2014.2427 10.1002/jlcr.1752 10.1016/S0140-6736(01)05625-2 10.1016/j.neuroimage.2004.09.034 10.1111/bpa.12196 10.1002/syn.20027 10.1007/s00259-011-1784-2 10.1089/dna.2016.3385 10.1007/s00259-016-3517-z 10.1007/s00259-017-3799-9 10.2967/jnumed.114.143727 10.1034/j.1600-0404.2001.103005309.x 10.1038/jcbfm.2014.46 10.1007/s004410051166 10.1111/bpa.12192 10.1176/appi.ajp.2016.15111417r 10.2967/jnumed.116.183202 10.1038/jcbfm.2010.63 10.1016/j.bbi.2013.06.010 10.1111/j.1460-9568.2006.04975.x 10.2967/jnumed.115.156083 10.1111/j.1471-4159.2007.04690.x 10.1038/sj.jcbfm.9600325 10.2967/jnumed.110.079459 10.2967/jnumed.107.044842 10.1002/ana.410260611 10.1016/0361-9230(87)90158-4 10.1006/excr.1998.4084 10.2967/jnumed.113.121020 10.1111/bpa.12195 10.1073/pnas.86.24.9813 10.1038/jcbfm.2012.46 10.1007/s10495-010-0460-5 10.1007/s00259-013-2359-1 10.1111/j.1471-4159.1989.tb07361.x 10.1038/jcbfm.2014.63 10.1038/mp.2016.248 10.1111/ejn.12946 10.1097/00001756-200111160-00012 10.1038/mp.2016.180 10.2967/jnumed.114.149443 10.1002/syn.20257 10.1111/jnc.13370 10.1177/0271678X17710182 10.1038/jcbfm.2012.131 10.1073/pnas.86.13.4897 10.1002/syn.20394 10.1016/S0969-8051(02)00410-9 10.1016/j.neuroimage.2007.11.011 10.1038/sj.jcbfm.9600092 10.1046/j.1471-4159.2000.0741694.x 10.1186/s13550-017-0304-1 10.1126/science.aaa1534 10.1038/jcbfm.2011.55 10.1016/j.tips.2006.06.005 10.1021/acs.jmedchem.5b00932 10.1111/bpa.12198 10.1016/j.bbadis.2015.11.011 10.1016/S0021-9258(19)47078-6 10.1038/jcbfm.2014.202 10.2967/jnumed.108.060186 10.1007/s00259-005-0052-8 10.1016/S0039-128X(96)00154-7 10.1002/syn.21970 10.1186/2191-219X-2-15 10.1371/journal.pone.0167307 10.1016/j.redox.2016.08.002 10.1212/WNL.53.9.2199 10.5694/j.1326-5377.2009.tb02371.x 10.1016/j.neuroimage.2006.11.003 10.1074/jbc.M114.549634 10.2967/jnumed.115.169078 10.1016/j.nucmedbio.2010.07.008 |
ContentType | Journal Article |
Copyright | The Author(s) 2017 The Author(s) 2017 2017 International Society for Cerebral Blood Flow and Metabolism |
Copyright_xml | – notice: The Author(s) 2017 – notice: The Author(s) 2017 2017 International Society for Cerebral Blood Flow and Metabolism |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1177/0271678X17748786 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1559-7016 |
EndPage | 224 |
ExternalDocumentID | PMC5951023 29256293 10_1177_0271678X17748786 10.1177_0271678X17748786 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- -Q- -TM .55 .GJ 0R~ 29K 2WC 36B 39C 3O- 4.4 53G 54M 5GY 5RE 5VS 70F 7X7 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AABMB AACKU AACMV AADUE AAEWN AAGGD AAGMC AAJIQ AAJPV AAKGS AANSI AAPEO AAQGT AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAVDI AAXOT AAYTG AAZBJ ABAWP ABAWZ ABCCA ABCJG ABDWY ABEIX ABFWQ ABHKI ABJNI ABJZC ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQNX ABQXT ABRHV ABUJY ABUWG ABVFX ABXGC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACNXM ACOFE ACOXC ACPRK ACROE ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADEBD ADEIA ADMPF ADNON ADRRZ ADTBJ ADUKL ADVBO ADZZY AECGH AENEX AEPTA AEQLS AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFFNX AFFZS AFKRA AFKRG AFMOU AFOSN AFQAA AFUIA AFVCE AGHKR AGKLV AGNHF AGPXR AGWFA AHDMH AHMBA AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ AJXGE ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS AMCVQ ANDLU AOIJS ARTOV AUTPY AYAKG B8M BAWUL BBNVY BBRGL BDDNI BENPR BHPHI BKIIM BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD C45 CAG CBRKF CCPQU CDWPY CFDXU COF CORYS CQQTX CS3 CUTAK D-I DC- DC. DIK DOPDO DV7 E3Z EBS EE. EJD EMOBN F5P FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GX1 H13 HCIFZ HMCUK HYE HZ~ J8X JSO K.F KQ8 LK8 M1P M7P O9- OK1 OVD P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO Q1R Q2X RNS RNTTT ROL RPM SASJQ SAUOL SCNPE SFC SHG SPQ SPV TEORI TR2 UKHRP W2D X7M YFH YOC ZGI ZONMY ZPPRI ZRKOI ZSSAH ZXP AAYXX AJGYC CITATION AAEJI AAPII AJVBE CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7X8 5PM AJHME |
ID | FETCH-LOGICAL-c500t-cfbb5bd6a893c43d94f8fc1495563d69bdb002f33d437697ae1c36e2dd9921e93 |
ISSN | 0271-678X 1559-7016 |
IngestDate | Thu Aug 21 18:21:54 EDT 2025 Tue Aug 05 10:52:44 EDT 2025 Mon Jul 21 05:58:19 EDT 2025 Thu Jul 03 08:34:01 EDT 2025 Thu Apr 24 23:03:35 EDT 2025 Tue Jun 17 22:29:07 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | positron emission tomography neuroinflammation microglia Translocator protein quantitation |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c500t-cfbb5bd6a893c43d94f8fc1495563d69bdb002f33d437697ae1c36e2dd9921e93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://journals.sagepub.com/doi/pdf/10.1177/0271678X17748786 |
PMID | 29256293 |
PQID | 1978732504 |
PQPubID | 23479 |
PageCount | 21 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5951023 proquest_miscellaneous_1978732504 pubmed_primary_29256293 crossref_citationtrail_10_1177_0271678X17748786 crossref_primary_10_1177_0271678X17748786 sage_journals_10_1177_0271678X17748786 |
PublicationCentury | 2000 |
PublicationDate | 2018-02-01 |
PublicationDateYYYYMMDD | 2018-02-01 |
PublicationDate_xml | – month: 02 year: 2018 text: 2018-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: United States – name: Sage UK: London, England |
PublicationTitle | Journal of cerebral blood flow and metabolism |
PublicationTitleAlternate | J Cereb Blood Flow Metab |
PublicationYear | 2018 |
Publisher | SAGE Publications |
Publisher_xml | – name: SAGE Publications |
References | Gerhard, Banati, Goerres 2003; 61 Braestrup, Squires 1977; 74 Woods, Zisterer, Williams 1996; 51 Gerhard, Schwarz, Myers 2005; 24 Kuhlmann, Guilarte 2000; 74 Owen, Howell, Tang 2010; 30 Le Fur, Perrier, Vaucher 1983; 32 Heneka, Carson, El Khoury 2015; 14 Narendran, Frankle 2016; 173 Papadopoulos, Baraldi, Guilarte 2006; 27 Graeber 2014; 24 Tu, Morohaku, Manna 2014; 289 Iversen, Hansen, Bender 2006; 33 Sileikyte, Blachly-Dyson, Sewell 2014; 289 Kreisl, Fujita, Fujimura 2010; 49 Eberl, Katsifis, Peyronneau 2017; 44 Rizzo, Veronese, Tonietto 2014; 34 Snyder, Van Antwerpen 1998; 294 Estes, McAllister 2014; 24 Gavish, Bachman, Shoukrun 1999; 51 Fan, Harold, Pasqualetti 2015; 56 Rusjan, Wilson, Bloomfield 2011; 31 Matheson, Plaven-Sigray, Forsberg 2017; 7 Brendel, Kleinberger, Probst 2017; 9 Goverman 2009; 9 Fujita, Imaizumi, Zoghbi 2008; 40 Zanotti-Fregonara, Zhang, Jenko 2014; 5 Collste, Forsberg, Varrone 2016; 43 Middleton, Kam, Liu 2017; 36 Hirsch, Decaudin, Susin 1998; 241 Lindemann, Koch, Degenhardt 2004; 45 Zeno, Veenman, Katz 2012; 12 Endres, Pomper, James 2009; 50 Gershen, Zanotti-Fregonara, Dustin 2015; 72 Frankle, Narendran, Wood 2017; 71 Veenman, Gavish 2012; 12 Golla, Boellaard, Oikonen 2015; 35 Yoder, Territo, Hutchins 2015; 42 Holmes, Hinz, Drake 2016; 21 Casteels, Koole, Celen 2012; 39 Sandiego, Gallezot, Pittman 2015; 112 Cagnin, Brooks, Kennedy 2001; 358 Li, Liu, Zheng 2015; 347 Zhang, Maeda, Furutsuka 2003; 13 Miyazawa, Hamel, Diksic 1998; 38 Chen, Guilarte 2008; 118 Chaki, Funakoshi, Yoshikawa 1999; 371 Feng, Svarer, Thomsen 2014; 55 Canat, Carayon, Bouaboula 1993; 52 Tu, Zhao, Hussein 2016; 157 Banati, Myers, Kreutzberg 1997; 26 Hardwick, Fertikh, Culty 1999; 59 Fan, Calsolaro, Atkinson 2016; 57 Wadsworth, Jones, Chau 2012; 22 Mukhin, Papadopoulos, Costa 1989; 86 Turkheimer, Edison, Pavese 2007; 48 Fujimura, Zoghbi, Simeon 2009; 50 Papadopoulos, Amri, Boujrad 1997; 62 Parola, Stump, Pepperl 1991; 266 Wilson, Garcia, Parkes 2008; 35 Filiou, Arefin, Moscato 2014; 15 De Vos, Dumont, Santens 1999; 736 Jucaite, Cselenyi, Arvidsson 2012; 2 Hannestad, DellaGioia, Gallezot 2013; 33 Kreisl, Jenko, Hines 2013; 33 Mattner, Bandin, Staykova 2011; 38 Cagnin, Myers, Gunn 2001; 124 Peyronneau, Saba, Goutal 2013; 41 Venneti, Wang, Nguyen 2008; 67 Banati, Middleton, Chan 2014; 5 Bloomfield, Howes, Turkheimer 2016; 173 Cumming, Pedersen, Minuzzi 2006; 59 Owen, Guo, Kalk 2014; 34 Svahn, Becker, Graeber 2014; 24 Veenman, Alten, Linnemannstons 2010; 15 Maschauer, Haller, Riss 2015; 135 Mitsui, Morimoto, Niwa 2017; 360 Venneti, Lopresti, Wang 2007; 102 Hirsch, Beyer, Malkowitz 1989; 35 Carson, Channing, Blasberg 1993; 13 Katsifis, Loc'h, Henderson 2011; 38 Betlazar, Middleton, Banati 2016; 9 Brown, Fujita, Fujimura 2007; 48 Besman, Yanagibashi, Lee 1989; 86 Antkiewicz-Michaluk, Guidotti, Krueger 1988; 34 Imaizumi, Briard, Zoghbi 2007; 61 Banati, Goerres, Myers 1999; 53 Jaremko, Jaremko, Giller 2014; 343 Alho, Varga, Krueger 1994; 5 Wang, Morgan, Spector 1984; 81 Kanegawa, Collste, Forsberg 2016; 54 Hammoud, Endres, Chander 2005; 11 Mattner, Mardon, Katsifis 2008; 35 Cumming, Maschauer, Riss 2014; 34 Morohaku, Pelton, Daugherty 2014; 155 Brown, Degenhardt, Kotoula 2000; 156 Wang, Zhai, Xue 2016; 11 Banati, Hickie 2009; 190 Luus, Hanani, Reynolds 2010; 53 Setiawan, Wilson, Mizrahi 2015; 72 Ikawa, Lohith, Shrestha 2017; 58 Guo, Colasanti, Owen 2013; 54 Owen, Narayan, Wells 2017; 37 Owen, Gunn, Rabiner 2011; 52 Fan, Lindemann, Feuilloley 2012; 12 Salinas, Searle, Gunn 2015; 35 Pinborg, Videbaek, Ziebell 2007; 34 Ikoma, Yasuno, Ito 2007; 27 Kropholler, Boellaard, Schuitemaker 2005; 25 Krueger, Papadopoulos 1990; 265 Varrone, Oikonen, Forsberg 2015; 42 Coughlin, Wang, Ambinder 2016; 6 Feeney, Scott, Raffel 2016; 43 Guo, Kalathur, Liu 2015; 347 Celen, Koole, De Angelis 2010; 51 Pedersen, Minuzzi, Wirenfeldt 2006; 24 Banati, Cagnin, Brooks 2001; 12 Cumming, Danielsen, Vafaee 2001; 103 Yeliseev, Krueger, Kaplan 1997; 94 Mizrahi, Rusjan, Kennedy 2012; 32 Maeda, Suhara, Zhang 2004; 52 Feng, Jensen, Thomsen 2017; 58 Zhao, Tu, Mukai 2016; 291 Lockhart, Davis, Matthews 2003; 30 Pandey, Flockerzi, Hauser 2011; 100 Lavisse, Guillermier, Herard 2012; 32 Coughlin, Wang, Minn 2017; 74 Black, Ikezaki, Santori 1990; 65 Pappata, Levasseur, Gunn 2000; 55 Liu, Middleton, Hatty 2014; 24 Sprengel, Werner, Seeburg 1989; 264 Schoemaker, Bliss, Yamamura 1981; 71 Basile, Weissman, Skolnick 1987; 19 Damont, Medran-Navarrete, Cacheux 2015; 58 Yaqub, van Berckel, Schuitemaker 2012; 32 Liu, Middleton, Kam 2017; 16 Eshleman, Murray 1989; 53 Yokokura, Terada, Bunai 2017; 37 Berk, Kapczinski, Andreazza 2011; 35 Lavisse, Garcia-Lorenzo, Peyronneau 2015; 56 Saba, Goutal, Kuhnast 2015; 42 Li, Papadopoulos 1998; 139 Banati 2002; 96 Junck, Olson, Ciliax 1989; 26 Asselin, Montgomery, Grasby 2007; 27 Owen, Yeo, Gunn 2012; 32 Inta, Lang, Borgwardt 2017; 43 Banati, Newcombe, Gunn 2000; 123 Janssen, Vugts, Funke 2016; 1862 Varrone, Mattsson, Forsberg 2013; 40 bibr76-0271678X17748786 bibr109-0271678X17748786 Sprengel R (bibr49-0271678X17748786) 1989; 264 bibr17-0271678X17748786 bibr33-0271678X17748786 bibr117-0271678X17748786 bibr133-0271678X17748786 bibr41-0271678X17748786 bibr84-0271678X17748786 bibr4-0271678X17748786 Antkiewicz-Michaluk L (bibr56-0271678X17748786) 1988; 34 bibr2-0271678X17748786 bibr100-0271678X17748786 bibr143-0271678X17748786 bibr94-0271678X17748786 bibr125-0271678X17748786 bibr151-0271678X17748786 bibr25-0271678X17748786 bibr68-0271678X17748786 bibr123-0271678X17748786 bibr115-0271678X17748786 bibr131-0271678X17748786 bibr102-0271678X17748786 bibr31-0271678X17748786 bibr15-0271678X17748786 bibr86-0271678X17748786 bibr78-0271678X17748786 bibr107-0271678X17748786 bibr99-0271678X17748786 bibr88-0271678X17748786 bibr141-0271678X17748786 bibr105-0271678X17748786 bibr23-0271678X17748786 bibr96-0271678X17748786 bibr110-0271678X17748786 bibr10-0271678X17748786 Krueger KE (bibr40-0271678X17748786) 1990; 265 bibr104-0271678X17748786 bibr155-0271678X17748786 bibr8-0271678X17748786 Parola AL (bibr48-0271678X17748786) 1991; 266 bibr147-0271678X17748786 bibr113-0271678X17748786 bibr120-0271678X17748786 bibr11-0271678X17748786 bibr80-0271678X17748786 bibr139-0271678X17748786 bibr7-0271678X17748786 bibr37-0271678X17748786 bibr64-0271678X17748786 bibr72-0271678X17748786 bibr146-0271678X17748786 bibr138-0271678X17748786 bibr98-0271678X17748786 bibr121-0271678X17748786 bibr29-0271678X17748786 bibr81-0271678X17748786 bibr112-0271678X17748786 bibr14-0271678X17748786 bibr87-0271678X17748786 bibr61-0271678X17748786 bibr22-0271678X17748786 Alho H (bibr77-0271678X17748786) 1994; 5 bibr95-0271678X17748786 bibr124-0271678X17748786 bibr135-0271678X17748786 bibr45-0271678X17748786 bibr92-0271678X17748786 bibr101-0271678X17748786 bibr119-0271678X17748786 bibr132-0271678X17748786 bibr79-0271678X17748786 bibr140-0271678X17748786 bibr127-0271678X17748786 bibr1-0271678X17748786 bibr53-0271678X17748786 bibr142-0271678X17748786 bibr134-0271678X17748786 bibr126-0271678X17748786 bibr24-0271678X17748786 bibr150-0271678X17748786 bibr50-0271678X17748786 bibr93-0271678X17748786 bibr26-0271678X17748786 bibr67-0271678X17748786 bibr69-0271678X17748786 bibr116-0271678X17748786 Luus C (bibr90-0271678X17748786) 2010; 53 bibr16-0271678X17748786 bibr59-0271678X17748786 bibr34-0271678X17748786 bibr42-0271678X17748786 bibr85-0271678X17748786 bibr108-0271678X17748786 bibr3-0271678X17748786 bibr44-0271678X17748786 bibr128-0271678X17748786 bibr136-0271678X17748786 bibr57-0271678X17748786 Inta D (bibr30-0271678X17748786) 2017; 43 bibr149-0271678X17748786 bibr60-0271678X17748786 bibr144-0271678X17748786 bibr28-0271678X17748786 bibr73-0271678X17748786 bibr91-0271678X17748786 bibr52-0271678X17748786 bibr152-0271678X17748786 bibr70-0271678X17748786 bibr154-0271678X17748786 bibr83-0271678X17748786 Gavish M (bibr46-0271678X17748786) 1999; 51 bibr18-0271678X17748786 bibr118-0271678X17748786 bibr5-0271678X17748786 Wang H (bibr62-0271678X17748786) 2016; 11 bibr157-0271678X17748786 bibr36-0271678X17748786 bibr38-0271678X17748786 Hirsch JD (bibr43-0271678X17748786) 1989; 35 bibr71-0271678X17748786 bibr20-0271678X17748786 bibr63-0271678X17748786 bibr89-0271678X17748786 bibr54-0271678X17748786 bibr97-0271678X17748786 Turkheimer FE (bibr103-0271678X17748786) 2007; 48 bibr156-0271678X17748786 bibr39-0271678X17748786 bibr13-0271678X17748786 bibr129-0271678X17748786 bibr130-0271678X17748786 bibr47-0271678X17748786 bibr21-0271678X17748786 bibr12-0271678X17748786 bibr55-0271678X17748786 bibr82-0271678X17748786 Zeno S (bibr66-0271678X17748786) 2012; 12 bibr19-0271678X17748786 Veenman L (bibr65-0271678X17748786) 2012; 12 bibr74-0271678X17748786 bibr145-0271678X17748786 bibr35-0271678X17748786 bibr6-0271678X17748786 bibr122-0271678X17748786 bibr137-0271678X17748786 Hardwick M (bibr75-0271678X17748786) 1999; 59 bibr32-0271678X17748786 Fan J (bibr51-0271678X17748786) 2012; 12 bibr111-0271678X17748786 bibr148-0271678X17748786 bibr9-0271678X17748786 bibr58-0271678X17748786 bibr106-0271678X17748786 bibr114-0271678X17748786 bibr153-0271678X17748786 bibr27-0271678X17748786 |
References_xml | – volume: 9 start-page: 8 year: 2017 article-title: Increase of TREM2 during aging of an Alzheimer's disease mouse model is paralleled by microglial activation and amyloidosis publication-title: Front Aging Neurosci – volume: 24 start-page: 991 year: 2006 end-page: 1000 article-title: Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain publication-title: Eur J Neurosci – volume: 53 start-page: 501 year: 2010 end-page: 510 article-title: The development of PET radioligands for imaging the translocator protein (18 kDa): what have we learned? publication-title: J Labelled Compd Radiopharm – volume: 12 start-page: 369 year: 2012 end-page: 386 article-title: Structural and functional evolution of the translocator protein (18 kDa) publication-title: Curr Mol Med – volume: 56 start-page: 1048 year: 2015 end-page: 1054 article-title: Optimized quantification of translocator protein radioligand (1)(8)F-DPA-714 uptake in the brain of genotyped healthy volunteers publication-title: J Nucl Med – volume: 190 start-page: S26 year: 2009 end-page: S32 article-title: Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders publication-title: Med J Aust – volume: 156 start-page: 125 year: 2000 end-page: 132 article-title: Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis publication-title: Cancer Lett – volume: 32 start-page: 1600 year: 2012 end-page: 1608 article-title: Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies publication-title: J Cereb Blood Flow Metab – volume: 42 start-page: 1738 year: 2015 end-page: 1745 article-title: Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [(18)F]DPA-714, a positron emission tomography imaging marker of glial activation publication-title: Eur J Neurosci – volume: 33 start-page: 810 year: 2006 end-page: 816 article-title: Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy publication-title: Eur J Nucl Med Mol Imaging – volume: 14 start-page: 388 year: 2015 end-page: 405 article-title: Neuroinflammation in Alzheimer's disease publication-title: Lancet Neurol – volume: 34 start-page: 1060 year: 2014 end-page: 1069 article-title: Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET data publication-title: J Cereb Blood Flow Metab – volume: 33 start-page: 53 year: 2013 end-page: 58 article-title: A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation publication-title: J Cereb Blood Flow Metab – volume: 32 start-page: 10809 year: 2012 end-page: 10818 article-title: Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging publication-title: J Neurosci – volume: 5 start-page: 5452 year: 2014 article-title: Positron emission tomography and functional characterization of a complete PBR/TSPO knockout publication-title: Nat Commun – volume: 35 start-page: 804 year: 2011 end-page: 817 article-title: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors publication-title: Neurosci Biobehav Rev – volume: 38 start-page: 137 year: 2011 end-page: 148 article-title: A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [(18)F]PBR102 and [(18)F]PBR111, in rat and primate plasma publication-title: Nucl Med Biol – volume: 56 start-page: 707 year: 2015 end-page: 713 article-title: Can studies of neuroinflammation in a TSPO genetic subgroup (HAB or MAB) be applied to the entire AD cohort? publication-title: J Nucl Med – volume: 9 start-page: 144 year: 2016 end-page: 156 article-title: The impact of high and low dose ionising radiation on the central nervous system publication-title: Redox Biol – volume: 81 start-page: 753 year: 1984 end-page: 756 article-title: Benzodiazepines that bind at peripheral sites inhibit cell proliferation publication-title: Proc Natl Acad Sci USA – volume: 32 start-page: 968 year: 2012 end-page: 972 article-title: Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA publication-title: J Cereb Blood Flow Metab – volume: 54 start-page: 1915 year: 2013 end-page: 1923 article-title: Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding publication-title: J Nucl Med – volume: 41 start-page: 122 year: 2013 end-page: 131 article-title: Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand publication-title: Drug Metab Dispos Biol Fate Chem – volume: 27 start-page: 378 year: 2007 end-page: 392 article-title: Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region publication-title: J Cereb Blood Flow Metab – volume: 74 start-page: 67 year: 2017 end-page: 74 article-title: Imaging of glial cell activation and white matter integrity in brains of active and recently retired National Football League players publication-title: JAMA Neurol – volume: 58 start-page: 7449 year: 2015 end-page: 7464 article-title: Novel pyrazolo[1,5-a]pyrimidines as translocator protein 18 kDa (TSPO) ligands: synthesis, in vitro biological evaluation, [(18)F]-labeling, and in vivo neuroinflammation PET images publication-title: J Med Chem – volume: 15 start-page: 201 year: 2014 end-page: 212 article-title: ‘Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared publication-title: Neurogenetics – volume: 32 start-page: 1839 year: 1983 end-page: 1847 article-title: Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)- -methyl- -(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies publication-title: Life Sci – volume: 135 start-page: 908 year: 2015 end-page: 917 article-title: Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain publication-title: J Neurochem – volume: 52 start-page: 283 year: 2004 end-page: 291 article-title: Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain publication-title: Synapse – volume: 358 start-page: 461 year: 2001 end-page: 467 article-title: In-vivo measurement of activated microglia in dementia publication-title: Lancet – volume: 34 start-page: 1450 year: 2007 end-page: 1453 article-title: [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region publication-title: Neuroimage – volume: 72 start-page: 268 year: 2015 end-page: 275 article-title: Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes publication-title: JAMA Psychiatry – volume: 2 start-page: 15 year: 2012 article-title: Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain – a PET study in control subjects publication-title: EJNMMI Res – volume: 96 start-page: 289 year: 2002 end-page: 299 article-title: Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? publication-title: J Physiol Paris – volume: 48 start-page: 2072 year: 2007 end-page: 2079 article-title: Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation publication-title: J Nucl Med – volume: 347 start-page: 551 year: 2015 end-page: 555 article-title: Protein structure. Structure and activity of tryptophan-rich TSPO proteins publication-title: Science – volume: 50 start-page: 1047 year: 2009 end-page: 1053 article-title: Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06 publication-title: J Nucl Med – volume: 51 start-page: 629 year: 1999 end-page: 650 article-title: Enigma of the peripheral benzodiazepine receptor publication-title: Pharmacol Rev – volume: 38 start-page: 19 year: 1998 end-page: 26 article-title: Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods publication-title: J Neurooncol – volume: 155 start-page: 89 year: 2014 end-page: 97 article-title: Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis publication-title: Endocrinology – volume: 42 start-page: 305 year: 2015 end-page: 308 article-title: Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake publication-title: Nucl Med Biol – volume: 55 start-page: 1052 year: 2000 end-page: 1054 article-title: Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195 publication-title: Neurology – volume: 53 start-page: 494 year: 1989 end-page: 502 article-title: Differential binding properties of the peripheral-type benzodiazepine ligands [3H]PK 11195 and [3H]Ro 5-4864 in trout and mouse brain membranes publication-title: J Neurochem – volume: 35 start-page: 766 year: 2015 end-page: 772 article-title: Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients publication-title: J Cereb Blood Flow Metab – volume: 1862 start-page: 425 year: 2016 end-page: 441 article-title: Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: recent developments in positron emission tomography publication-title: Biochim Biophys Acta – volume: 48 start-page: 158 year: 2007 end-page: 167 article-title: Reference and target region modeling of [11C]-(R)-PK11195 brain studies publication-title: J Nucl Med – volume: 265 start-page: 15015 year: 1990 end-page: 15022 article-title: Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells publication-title: J Biol Chem – volume: 37 start-page: 877 year: 2017 end-page: 889 article-title: Depiction of microglial activation in aging and dementia: positron emission tomography with [11C]DPA713 versus [11C](R)PK11195 publication-title: J Cereb Blood Flow Metab – volume: 52 start-page: 24 year: 2011 end-page: 32 article-title: Mixed-affinity binding in humans with 18-kDa translocator protein ligands publication-title: J Nucl Med – volume: 24 start-page: 631 year: 2014 end-page: 653 article-title: The 18 kDa translocator protein, microglia and neuroinflammation publication-title: Brain Pathol – volume: 343 start-page: 1363 year: 2014 end-page: 1366 article-title: Structure of the mitochondrial translocator protein in complex with a diagnostic ligand publication-title: Science – volume: 30 start-page: 199 year: 2003 end-page: 206 article-title: The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker publication-title: Nucl Med Biol – volume: 21 start-page: 1672 year: 2016 end-page: 1679 article-title: In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study publication-title: Mol Psychiatry – volume: 61 start-page: 686 year: 2003 end-page: 689 article-title: [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy publication-title: Neurology – volume: 13 start-page: 24 year: 1993 end-page: 42 article-title: Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography publication-title: J Cereb Blood Flow Metab – volume: 103 start-page: 309 year: 2001 end-page: 315 article-title: Normalization of markers for dopamine innervation in striatum of MPTP-lesioned miniature pigs with intrastriatal grafts publication-title: Acta Neurol Scand – volume: 289 start-page: 27444 year: 2014 end-page: 27454 article-title: Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis publication-title: J Biol Chem – volume: 266 start-page: 14082 year: 1991 end-page: 14087 article-title: Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein publication-title: J Biol Chem – volume: 347 start-page: 555 year: 2015 end-page: 558 article-title: Protein structure. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism publication-title: Science – volume: 58 start-page: 989 year: 2017 end-page: 995 article-title: The variability of translocator protein signal in brain and blood of genotyped healthy humans using in vivo 123I-CLINDE SPECT imaging: a test-retest study publication-title: J Nucl Med – volume: 67 start-page: 1001 year: 2008 end-page: 1010 article-title: The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders publication-title: J Neuropathol Exp Neurol – volume: 40 start-page: 43 year: 2008 end-page: 52 article-title: Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation publication-title: Neuroimage – volume: 360 start-page: 457 year: 2017 end-page: 465 article-title: Quantification of ONO-2952 occupancy of 18-kDa translocator protein in conscious monkey brains using positron emission tomography publication-title: J Pharmacol Exp Ther – volume: 57 start-page: 1753 year: 2016 end-page: 1759 article-title: Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein publication-title: J Nucl Med – volume: 112 start-page: 12468 year: 2015 end-page: 12473 article-title: Imaging robust microglial activation after lipopolysaccharide administration in humans with PET publication-title: Proc Natl Acad Sci U S A – volume: 34 start-page: 1148 year: 2014 end-page: 1156 article-title: Radiosynthesis and validation of (1)(8)F-FP-CMT, a phenyltropane with superior properties for imaging the dopamine transporter in living brain publication-title: J Cereb Blood Flow Metab – volume: 71 start-page: e21970 issue: 7 year: 2017 article-title: Brain translocator protein occupancy by ONO-2952 in healthy adults: a phase 1 PET study using [11 C]PBR28 publication-title: Synapse – volume: 35 start-page: 305 year: 2008 end-page: 314 article-title: Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors publication-title: Nucl Med Biol – volume: 51 start-page: 1584 year: 2010 end-page: 1591 article-title: Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain publication-title: J Nucl Med – volume: 59 start-page: 418 year: 2006 end-page: 426 article-title: Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography publication-title: Synapse – volume: 36 start-page: 103 year: 2017 end-page: 108 article-title: Epigenetic silencing of the human 18 kDa translocator protein in a T cell leukemia cell line publication-title: DNA Cell Biol – volume: 157 start-page: 1110 year: 2016 end-page: 1121 article-title: Translocator protein (TSPO) affects mitochondrial fatty acid oxidation in steroidogenic cells publication-title: Endocrinology – volume: 72 start-page: 882 year: 2015 end-page: 888 article-title: Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein publication-title: JAMA Neurol – volume: 35 start-page: 779 year: 2008 end-page: 789 article-title: Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS) publication-title: Eur J Nucl Med Mol Imaging – volume: 54 start-page: 149 year: 2016 end-page: 157 article-title: In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects publication-title: Brain Behav Immun – volume: 34 start-page: 989 year: 2014 end-page: 994 article-title: Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study publication-title: J Cereb Blood Flow Metab – volume: 291 start-page: 1591 year: 2016 end-page: 1603 article-title: Mitochondrial translocator protein (TSPO) function is not essential for heme biosynthesis publication-title: J Biol Chem – volume: 27 start-page: 173 year: 2007 end-page: 184 article-title: Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106 publication-title: J Cereb Blood Flow Metab – volume: 173 start-page: 537 year: 2016 end-page: 538 article-title: Response to Narendran and Frankle: The interpretation of PET microglial imaging in schizophrenia publication-title: Am J Psychiatry – volume: 7 start-page: 58 year: 2017 article-title: Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data publication-title: EJNMMI Res – volume: 12 start-page: 398 year: 2012 end-page: 412 article-title: The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression publication-title: Curr Mol Med – volume: 12 start-page: 3439 year: 2001 end-page: 3442 article-title: Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury publication-title: Neuroreport – volume: 86 start-page: 9813 year: 1989 end-page: 9816 article-title: Mitochondrial benzodiazepine receptors regulate steroid biosynthesis publication-title: Proc Natl Acad Sci USA – volume: 34 start-page: 272 year: 1988 end-page: 278 article-title: Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands publication-title: Mol Pharmacol – volume: 13 start-page: 201 year: 2003 end-page: 204 article-title: [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR) publication-title: Bioorg Med Chem Lett – volume: 27 start-page: 402 year: 2006 end-page: 409 article-title: Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function publication-title: Trends Pharmacol Sci – volume: 52 start-page: 107 year: 1993 end-page: 118 article-title: Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells publication-title: Life Sci – volume: 26 start-page: 77 year: 1997 end-page: 82 article-title: PK (‘peripheral benzodiazepine')-binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia publication-title: J Neurocytol – volume: 74 start-page: 1694 year: 2000 end-page: 1704 article-title: Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity publication-title: J Neurochem – volume: 124 start-page: 2014 year: 2001 end-page: 2027 article-title: In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion publication-title: Brain – volume: 26 start-page: 752 year: 1989 end-page: 758 article-title: PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site publication-title: Ann Neurol – volume: 19 start-page: 1 year: 1987 end-page: 7 article-title: Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex publication-title: Brain Res Bull – volume: 45 start-page: 723 year: 2004 end-page: 733 article-title: A novel Arabidopsis thaliana protein is a functional peripheral-type benzodiazepine receptor publication-title: Plant Cell Physiol – volume: 12 start-page: 494 year: 2012 end-page: 501 article-title: The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS) publication-title: Curr Mol Med – volume: 61 start-page: 595 year: 2007 end-page: 605 article-title: Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain publication-title: Synapse – volume: 35 start-page: 304 year: 2015 end-page: 311 article-title: The simplified reference tissue model: model assumption violations and their impact on binding potential publication-title: J Cereb Blood Flow Metab – volume: 24 start-page: 665 year: 2014 end-page: 670 article-title: Emergent properties of microglia publication-title: Brain Pathol – volume: 38 start-page: 1516 year: 2011 end-page: 1528 article-title: Evaluation of [(1)(2)(3)I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation publication-title: Eur J Nucl Med Mol Imaging – volume: 74 start-page: 3805 year: 1977 end-page: 3809 article-title: Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding publication-title: Proc Natl Acad Sci U S A – volume: 43 start-page: 493 year: 2017 end-page: 496 article-title: Microglia activation and schizophrenia: lessons from the effects of minocycline on postnatal neurogenesis, neuronal survival and synaptic pruning publication-title: Schizophr Bull – volume: 24 start-page: 623 year: 2014 end-page: 630 article-title: Alterations in immune cells and mediators in the brain: it's not always neuroinflammation! publication-title: Brain Pathol – volume: 100 start-page: 2347 year: 2011 end-page: 2355 article-title: Modeling the light- and redox-dependent interaction of PpsR/AppA in publication-title: Biophys J – volume: 39 start-page: 1467 year: 2012 end-page: 1477 article-title: Preclinical evaluation and quantification of [(1)(8)F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain publication-title: Eur J Nucl Med Mol Imaging – volume: 24 start-page: 620 year: 2014 end-page: 622 article-title: Neuroinflammation: no rose by any other name publication-title: Brain Pathol – volume: 32 start-page: 1 year: 2012 end-page: 5 article-title: An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 publication-title: J Cereb Blood Flow Metab – volume: 58 start-page: 320 year: 2017 end-page: 325 article-title: 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain publication-title: J Nucl Med – volume: 5 start-page: 1005 year: 1994 end-page: 1014 article-title: Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth publication-title: Cell Growth Differ – volume: 35 start-page: 157 year: 1989 end-page: 163 article-title: Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control publication-title: Mol Pharmacol – volume: 123 start-page: 2321 year: 2000 end-page: 2337 article-title: The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity publication-title: Brain – volume: 25 start-page: 842 year: 2005 end-page: 851 article-title: Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies publication-title: J Cereb Blood Flow Metab – volume: 43 start-page: 2201 year: 2016 end-page: 2210 article-title: Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain publication-title: Eur J Nucl Med Mol Imaging – volume: 65 start-page: 93 year: 1990 end-page: 97 article-title: Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man publication-title: Cancer – volume: 102 start-page: 2118 year: 2007 end-page: 2131 article-title: A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation publication-title: J Neurochem – volume: 55 start-page: 1966 year: 2014 end-page: 1972 article-title: In vivo quantification of cerebral translocator protein binding in humans using 6-chloro-2-(4′-123I-iodophenyl)-3-(N,N-diethyl)-imidazo[1,2-a]pyridine-3-acetamid e SPECT publication-title: J Nucl Med – volume: 94 start-page: 5101 year: 1997 end-page: 5106 article-title: A mammalian mitochondrial drug receptor functions as a bacterial “oxygen” sensor publication-title: Proc Natl Acad Sci USA – volume: 43 start-page: 173 year: 2016 end-page: 183 article-title: Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects publication-title: Eur J Nucl Med Mol Imaging – volume: 139 start-page: 4991 year: 1998 end-page: 4997 article-title: Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern publication-title: Endocrinology – volume: 40 start-page: 921 year: 2013 end-page: 931 article-title: In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients publication-title: Eur J Nucl Med Mol Imaging – volume: 31 start-page: 1807 year: 2011 end-page: 1816 article-title: Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography publication-title: J Cereb Blood Flow Metab – volume: 294 start-page: 161 year: 1998 end-page: 168 article-title: Evidence for a diazepam-binding inhibitor (DBI) benzodiazepine receptor-like mechanism in ecdysteroidogenesis by the insect prothoracic gland publication-title: Cell Tissue Res – volume: 30 start-page: 1608 year: 2010 end-page: 1618 article-title: Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation publication-title: J Cereb Blood Flow Metab – volume: 53 start-page: 2199 year: 1999 end-page: 2203 article-title: [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis publication-title: Neurology – volume: 37 start-page: 2679 year: 2017 end-page: 2690 article-title: Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans publication-title: J Cereb Blood Flow Metab – volume: 241 start-page: 426 year: 1998 end-page: 434 article-title: PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection publication-title: Exp Cell Res – volume: 49 start-page: 2924 year: 2010 end-page: 2932 article-title: Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker publication-title: Neuroimage – volume: 59 start-page: 831 year: 1999 end-page: 842 article-title: Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol publication-title: Cancer Res – volume: 62 start-page: 21 year: 1997 end-page: 28 article-title: Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis publication-title: Steroids – volume: 16 start-page: 436 year: 2017 end-page: 447 article-title: Functional gains in energy and cell metabolism after TSPO gene insertion publication-title: Cell Cycle – volume: 22 start-page: 1308 year: 2012 end-page: 1313 article-title: [(1)(8)F]GE-180: a novel fluorine-18 labelled PET tracer for imaging translocator protein 18 kDa (TSPO) publication-title: Bioorg Med Chem Lett – volume: 44 start-page: 296 year: 2017 end-page: 307 article-title: Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111 publication-title: Eur J Nucl Med Mol Imaging – volume: 736 start-page: 61 year: 1999 end-page: 66 article-title: High-performance liquid chromatographic determination of [11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide in mouse plasma and tissue and in human plasma publication-title: J Chromatogr B Biomed Sci Appl – volume: 86 start-page: 4897 year: 1989 end-page: 4901 article-title: Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor publication-title: Proc Natl Acad Sci U S A – volume: 15 start-page: 753 year: 2010 end-page: 768 article-title: Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines: a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein publication-title: Apoptosis – volume: 71 start-page: 173 year: 1981 end-page: 175 article-title: Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex publication-title: Eur J Pharmacol – volume: 5 start-page: 963 year: 2014 end-page: 971 article-title: Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971 publication-title: ACS Chem Neurosci – volume: 289 start-page: 13769 year: 2014 end-page: 13781 article-title: Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (translocator protein of 18 kDa (TSPO)) publication-title: J Biol Chem – volume: 9 start-page: 393 year: 2009 end-page: 407 article-title: Autoimmune T cell responses in the central nervous system publication-title: Nat Rev Immunol – volume: 173 start-page: 536 year: 2016 end-page: 537 article-title: Comment on analyses and conclusions of “microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study publication-title: Am J Psychiatry – volume: 51 start-page: 1283 year: 1996 end-page: 1292 article-title: Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver publication-title: Biochem Pharmacol – volume: 24 start-page: 591 year: 2005 end-page: 595 article-title: Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study publication-title: NeuroImage – volume: 42 start-page: 438 year: 2015 end-page: 446 article-title: Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects publication-title: Eur J Nucl Med Mol Imaging – volume: 11 start-page: 346 year: 2005 end-page: 355 article-title: Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS publication-title: J Neurovirol – volume: 6 start-page: e777 year: 2016 article-title: In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma publication-title: Transl Psychiatry – volume: 33 start-page: 131 year: 2013 end-page: 138 article-title: The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [(1)(1)C]PBR28 PET study publication-title: Brain Behav Immun – volume: 11 start-page: e0167307 year: 2016 article-title: Global deletion of TSPO does not affect the viability and gene expression profile publication-title: PLoS One – volume: 50 start-page: 1276 year: 2009 end-page: 1282 article-title: Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans publication-title: J Nucl Med – volume: 371 start-page: 197 year: 1999 end-page: 204 article-title: Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors publication-title: Eur J Pharmacol – volume: 264 start-page: 20415 year: 1989 end-page: 20421 article-title: Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor publication-title: J Biol Chem – volume: 118 start-page: 1 year: 2008 end-page: 17 article-title: Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair publication-title: Pharmacol Ther – volume: 51 start-page: 629 year: 1999 ident: bibr46-0271678X17748786 publication-title: Pharmacol Rev doi: 10.1016/S0031-6997(24)01424-8 – ident: bibr72-0271678X17748786 doi: 10.1210/en.2015-1795 – ident: bibr105-0271678X17748786 doi: 10.1038/jcbfm.2012.59 – ident: bibr136-0271678X17748786 doi: 10.1016/j.bmcl.2011.12.084 – ident: bibr57-0271678X17748786 doi: 10.1126/science.1248725 – ident: bibr67-0271678X17748786 doi: 10.1073/pnas.81.3.753 – ident: bibr11-0271678X17748786 doi: 10.1073/pnas.1511003112 – ident: bibr148-0271678X17748786 doi: 10.1038/jcbfm.2014.261 – ident: bibr54-0271678X17748786 doi: 10.1126/science.1260590 – ident: bibr108-0271678X17748786 doi: 10.1038/jcbfm.1993.6 – ident: bibr74-0271678X17748786 doi: 10.1016/S0304-3835(00)00451-1 – ident: bibr98-0271678X17748786 doi: 10.1080/13550280500187351 – ident: bibr8-0271678X17748786 doi: 10.1023/A:1018567510105 – ident: bibr21-0271678X17748786 doi: 10.1001/jamaneurol.2016.3764 – ident: bibr61-0271678X17748786 doi: 10.1074/jbc.M114.578286 – ident: bibr142-0271678X17748786 doi: 10.1177/0271678X16646788 – ident: bibr12-0271678X17748786 doi: 10.1523/JNEUROSCI.1487-12.2012 – ident: bibr6-0271678X17748786 doi: 10.1038/nri2550 – ident: bibr26-0271678X17748786 – ident: bibr135-0271678X17748786 doi: 10.1124/dmd.112.046342 – ident: bibr45-0271678X17748786 doi: 10.1073/pnas.94.10.5101 – ident: bibr53-0271678X17748786 doi: 10.1093/pcp/pch088 – ident: bibr80-0271678X17748786 doi: 10.1016/j.pharmthera.2007.12.004 – ident: bibr81-0271678X17748786 doi: 10.1016/j.bbi.2016.01.019 – ident: bibr20-0271678X17748786 doi: 10.1093/brain/124.10.2014 – ident: bibr104-0271678X17748786 doi: 10.1212/01.WNL.0000078192.95645.E6 – ident: bibr15-0271678X17748786 doi: 10.1093/brain/123.11.2321 – volume: 34 start-page: 272 year: 1988 ident: bibr56-0271678X17748786 publication-title: Mol Pharmacol doi: 10.1016/S0026-895X(25)09743-3 – ident: bibr59-0271678X17748786 doi: 10.1210/en.2013-1556 – ident: bibr151-0271678X17748786 doi: 10.1016/S0014-2999(99)00118-1 – ident: bibr111-0271678X17748786 doi: 10.2967/jnumed.117.195396 – ident: bibr133-0271678X17748786 doi: 10.1007/s00259-012-2163-3 – ident: bibr141-0271678X17748786 doi: 10.3389/fnagi.2017.00008 – ident: bibr71-0271678X17748786 doi: 10.1074/jbc.M115.686360 – ident: bibr145-0271678X17748786 doi: 10.1007/s00259-014-2955-8 – ident: bibr114-0271678X17748786 doi: 10.1038/jcbfm.2011.147 – ident: bibr95-0271678X17748786 doi: 10.2967/jnumed.116.178335 – volume: 12 start-page: 369 year: 2012 ident: bibr51-0271678X17748786 publication-title: Curr Mol Med – ident: bibr27-0271678X17748786 doi: 10.1176/appi.ajp.2016.15111417 – ident: bibr122-0271678X17748786 doi: 10.1124/jpet.116.238568 – ident: bibr147-0271678X17748786 doi: 10.1038/tp.2016.40 – volume: 265 start-page: 15015 year: 1990 ident: bibr40-0271678X17748786 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)77217-7 – ident: bibr63-0271678X17748786 doi: 10.1210/endo.139.12.6390 – ident: bibr73-0271678X17748786 doi: 10.1016/0006-2952(96)00034-2 – ident: bibr129-0271678X17748786 doi: 10.1007/s00259-015-3149-8 – volume: 12 start-page: 494 year: 2012 ident: bibr66-0271678X17748786 publication-title: Curr Mol Med – ident: bibr37-0271678X17748786 doi: 10.1016/0014-2999(81)90405-2 – ident: bibr126-0271678X17748786 doi: 10.2967/jnumed.116.178996 – ident: bibr134-0271678X17748786 doi: 10.2967/jnumed.110.077040 – ident: bibr44-0271678X17748786 doi: 10.1016/j.bpj.2011.04.017 – ident: bibr152-0271678X17748786 doi: 10.1016/S0960-894X(02)00886-7 – ident: bibr38-0271678X17748786 doi: 10.1016/0024-3205(83)90062-0 – volume: 35 start-page: 157 year: 1989 ident: bibr43-0271678X17748786 publication-title: Mol Pharmacol doi: 10.1016/S0026-895X(25)10080-1 – ident: bibr36-0271678X17748786 doi: 10.1073/pnas.74.9.3805 – ident: bibr146-0271678X17748786 doi: 10.2967/jnumed.109.062265 – ident: bibr87-0271678X17748786 doi: 10.1097/NEN.0b013e318188b204 – ident: bibr84-0271678X17748786 doi: 10.1002/1097-0142(19900101)65:1<93::AID-CNCR2820650120>3.0.CO;2-1 – ident: bibr18-0271678X17748786 doi: 10.1212/WNL.55.7.1052 – ident: bibr139-0271678X17748786 doi: 10.1007/s00259-016-3444-z – ident: bibr119-0271678X17748786 doi: 10.1016/j.nucmedbio.2007.12.009 – ident: bibr19-0271678X17748786 doi: 10.1001/jamaneurol.2015.0941 – ident: bibr86-0271678X17748786 doi: 10.1023/A:1005933226966 – ident: bibr96-0271678X17748786 doi: 10.1016/j.nucmedbio.2014.11.003 – ident: bibr100-0271678X17748786 doi: 10.1038/sj.jcbfm.9600340 – ident: bibr150-0271678X17748786 doi: 10.1016/S0378-4347(99)00439-9 – ident: bibr125-0271678X17748786 doi: 10.1021/cn500138n – ident: bibr23-0271678X17748786 doi: 10.1016/j.neubiorev.2010.10.001 – ident: bibr28-0271678X17748786 doi: 10.1016/S0928-4257(02)00018-9 – ident: bibr9-0271678X17748786 doi: 10.1038/ncomms6452 – ident: bibr110-0271678X17748786 doi: 10.1038/jcbfm.2014.55 – ident: bibr120-0271678X17748786 doi: 10.1016/j.neuroimage.2009.11.056 – ident: bibr5-0271678X17748786 doi: 10.1007/s10048-014-0409-x – ident: bibr14-0271678X17748786 doi: 10.1016/S1474-4422(15)70016-5 – ident: bibr117-0271678X17748786 doi: 10.1093/ijnp/pyw077 – ident: bibr156-0271678X17748786 doi: 10.1007/s00259-007-0645-5 – ident: bibr124-0271678X17748786 doi: 10.1177/0271678X17699223 – ident: bibr69-0271678X17748786 doi: 10.1080/15384101.2017.1281477 – volume: 266 start-page: 14082 year: 1991 ident: bibr48-0271678X17748786 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)92812-7 – ident: bibr79-0271678X17748786 doi: 10.1016/0024-3205(93)90293-C – ident: bibr22-0271678X17748786 doi: 10.1001/jamapsychiatry.2014.2427 – volume: 53 start-page: 501 year: 2010 ident: bibr90-0271678X17748786 publication-title: J Labelled Compd Radiopharm doi: 10.1002/jlcr.1752 – ident: bibr13-0271678X17748786 doi: 10.1016/S0140-6736(01)05625-2 – ident: bibr16-0271678X17748786 doi: 10.1016/j.neuroimage.2004.09.034 – ident: bibr3-0271678X17748786 doi: 10.1111/bpa.12196 – ident: bibr121-0271678X17748786 doi: 10.1002/syn.20027 – ident: bibr78-0271678X17748786 doi: 10.1007/s00259-011-1784-2 – ident: bibr70-0271678X17748786 doi: 10.1089/dna.2016.3385 – ident: bibr130-0271678X17748786 doi: 10.1007/s00259-016-3517-z – ident: bibr140-0271678X17748786 doi: 10.1007/s00259-017-3799-9 – ident: bibr157-0271678X17748786 doi: 10.2967/jnumed.114.143727 – ident: bibr88-0271678X17748786 doi: 10.1034/j.1600-0404.2001.103005309.x – ident: bibr144-0271678X17748786 doi: 10.1038/jcbfm.2014.46 – ident: bibr52-0271678X17748786 doi: 10.1007/s004410051166 – ident: bibr2-0271678X17748786 doi: 10.1111/bpa.12192 – ident: bibr25-0271678X17748786 doi: 10.1176/appi.ajp.2016.15111417r – ident: bibr97-0271678X17748786 doi: 10.2967/jnumed.116.183202 – ident: bibr83-0271678X17748786 doi: 10.1038/jcbfm.2010.63 – ident: bibr153-0271678X17748786 doi: 10.1016/j.bbi.2013.06.010 – ident: bibr10-0271678X17748786 doi: 10.1111/j.1460-9568.2006.04975.x – ident: bibr106-0271678X17748786 doi: 10.2967/jnumed.115.156083 – ident: bibr149-0271678X17748786 doi: 10.1111/j.1471-4159.2007.04690.x – ident: bibr143-0271678X17748786 doi: 10.1038/sj.jcbfm.9600325 – ident: bibr113-0271678X17748786 doi: 10.2967/jnumed.110.079459 – ident: bibr34-0271678X17748786 doi: 10.2967/jnumed.107.044842 – ident: bibr32-0271678X17748786 doi: 10.1002/ana.410260611 – volume: 48 start-page: 158 year: 2007 ident: bibr103-0271678X17748786 publication-title: J Nucl Med – ident: bibr47-0271678X17748786 doi: 10.1016/0361-9230(87)90158-4 – ident: bibr68-0271678X17748786 doi: 10.1006/excr.1998.4084 – ident: bibr127-0271678X17748786 doi: 10.2967/jnumed.113.121020 – ident: bibr4-0271678X17748786 doi: 10.1111/bpa.12195 – ident: bibr41-0271678X17748786 doi: 10.1073/pnas.86.24.9813 – ident: bibr116-0271678X17748786 doi: 10.1038/jcbfm.2012.46 – ident: bibr64-0271678X17748786 doi: 10.1007/s10495-010-0460-5 – ident: bibr118-0271678X17748786 doi: 10.1007/s00259-013-2359-1 – ident: bibr50-0271678X17748786 doi: 10.1111/j.1471-4159.1989.tb07361.x – ident: bibr89-0271678X17748786 doi: 10.1038/jcbfm.2014.63 – ident: bibr7-0271678X17748786 doi: 10.1038/mp.2016.248 – ident: bibr91-0271678X17748786 doi: 10.1111/ejn.12946 – ident: bibr29-0271678X17748786 doi: 10.1097/00001756-200111160-00012 – ident: bibr102-0271678X17748786 doi: 10.1038/mp.2016.180 – ident: bibr35-0271678X17748786 doi: 10.2967/jnumed.114.149443 – ident: bibr85-0271678X17748786 doi: 10.1002/syn.20257 – ident: bibr92-0271678X17748786 doi: 10.1111/jnc.13370 – ident: bibr82-0271678X17748786 doi: 10.1177/0271678X17710182 – ident: bibr115-0271678X17748786 doi: 10.1038/jcbfm.2012.131 – ident: bibr39-0271678X17748786 doi: 10.1073/pnas.86.13.4897 – ident: bibr93-0271678X17748786 doi: 10.1002/syn.20394 – ident: bibr137-0271678X17748786 doi: 10.1016/S0969-8051(02)00410-9 – ident: bibr112-0271678X17748786 doi: 10.1016/j.neuroimage.2007.11.011 – ident: bibr109-0271678X17748786 doi: 10.1038/sj.jcbfm.9600092 – ident: bibr76-0271678X17748786 doi: 10.1046/j.1471-4159.2000.0741694.x – ident: bibr94-0271678X17748786 doi: 10.1186/s13550-017-0304-1 – volume: 43 start-page: 493 year: 2017 ident: bibr30-0271678X17748786 publication-title: Schizophr Bull – ident: bibr55-0271678X17748786 doi: 10.1126/science.aaa1534 – ident: bibr131-0271678X17748786 doi: 10.1038/jcbfm.2011.55 – ident: bibr42-0271678X17748786 doi: 10.1016/j.tips.2006.06.005 – ident: bibr154-0271678X17748786 doi: 10.1021/acs.jmedchem.5b00932 – ident: bibr1-0271678X17748786 doi: 10.1111/bpa.12198 – ident: bibr17-0271678X17748786 doi: 10.1016/j.bbadis.2015.11.011 – volume: 264 start-page: 20415 year: 1989 ident: bibr49-0271678X17748786 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)47078-6 – volume: 59 start-page: 831 year: 1999 ident: bibr75-0271678X17748786 publication-title: Cancer Res – ident: bibr99-0271678X17748786 doi: 10.1038/jcbfm.2014.202 – ident: bibr132-0271678X17748786 doi: 10.2967/jnumed.108.060186 – ident: bibr107-0271678X17748786 doi: 10.1007/s00259-005-0052-8 – ident: bibr58-0271678X17748786 doi: 10.1016/S0039-128X(96)00154-7 – ident: bibr123-0271678X17748786 doi: 10.1002/syn.21970 – ident: bibr128-0271678X17748786 doi: 10.1186/2191-219X-2-15 – volume: 11 start-page: e0167307 year: 2016 ident: bibr62-0271678X17748786 publication-title: PLoS One doi: 10.1371/journal.pone.0167307 – ident: bibr31-0271678X17748786 doi: 10.1016/j.redox.2016.08.002 – ident: bibr33-0271678X17748786 doi: 10.1212/WNL.53.9.2199 – ident: bibr24-0271678X17748786 doi: 10.5694/j.1326-5377.2009.tb02371.x – volume: 12 start-page: 398 year: 2012 ident: bibr65-0271678X17748786 publication-title: Curr Mol Med – ident: bibr101-0271678X17748786 doi: 10.1016/j.neuroimage.2006.11.003 – ident: bibr60-0271678X17748786 doi: 10.1074/jbc.M114.549634 – ident: bibr138-0271678X17748786 doi: 10.2967/jnumed.115.169078 – volume: 5 start-page: 1005 year: 1994 ident: bibr77-0271678X17748786 publication-title: Cell Growth Differ – ident: bibr155-0271678X17748786 doi: 10.1016/j.nucmedbio.2010.07.008 |
SSID | ssj0008355 |
Score | 2.532254 |
SecondaryResourceType | review_article |
Snippet | The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of... The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-(... The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ C]-(... The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [11C]-(... The first phase of molecular brain imaging of microglial activation in neuroinflammatory conditions began some 20 years ago with the introduction of [ 11 C]-(... |
SourceID | pubmedcentral proquest pubmed crossref sage |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 204 |
SubjectTerms | Biomarkers - analysis Humans Inflammation - diagnosis Inflammation - diagnostic imaging Inflammation - pathology Microglia - pathology Nervous System Diseases - diagnosis Nervous System Diseases - diagnostic imaging Nervous System Diseases - metabolism Positron-Emission Tomography Review Tomography, Emission-Computed, Single-Photon |
Title | Sifting through the surfeit of neuroinflammation tracers |
URI | https://journals.sagepub.com/doi/full/10.1177/0271678X17748786 https://www.ncbi.nlm.nih.gov/pubmed/29256293 https://www.proquest.com/docview/1978732504 https://pubmed.ncbi.nlm.nih.gov/PMC5951023 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF6F8gAvCFoOc8lIqBJCpt7Dxz42EahCKlSilfJm2eu1GhLbUeI8tL-DH8zsYcc5QNAXJ_E6nsTzeXbW880MQu-FWnPEWHiZxKnHYrCDXPrSk0ywUBBWsFjlO59_C8-u2NdxMB4MfvVYS6sm-yRu9-aV3EWrsA_0qrJk_0Oz3UlhB7wH_cIWNAzbf9Lxj0lh-jzYZjvKiVyuFoWc6Pi-rlUJckDpJkFRNYQQlvK-xyOFIRVGnhk2-8diVhu6cCkbgMqsLTaoCdVlaZuh9KmFQxWyMRgY_qwXHe4u0mZqiNzfy2na0YGH4LBOl3NphvoEfvsYAsctc3kj_rX_SSOJsAdz4thMOdbOBtyLfJNm2RpiGvcAR_pW1XQothM0MUnXu7ZfR5-VNCUMPsFazJTZ7kFhXmosEA6uHjG9GbfqbV-cjwLldhJ6D90nsPjQKeTjNXEIfFZNjG3_1jr4fbItXJWatpI2_Z6dxcwuJ7dHLNS-zuVj9MhCwj01iHuCBrI6REenVdrU5Y177GrasI7HHKIHo7Zl4BGKLSBdC0h4la4FpFsX7g4gXQvIp-jqy-fL0ZlnW3N4IvD9xhNFlgVZHqbg7gpGc86KuBBqtR2ENA95livvr6A0ZzCD8SiVWNBQkjznnGDJ6TN0UNWVfIFcQEIYcwxuPSNgHtIsCkWY-lTEOWNSBg46aS9cImzdetU-ZZbgtlT91lV30IfuG3NTs-Uvx75rdZHAxVLRsrSS9WqZYA5zGVUV_hz03OimO1urVAdFG1rrDlBF2zdHqsm1Lt5useWgY6XfxFqT5R9_4Ms7i3iFHq5v1NfooFms5BvwoJvsrQb0b7iAw80 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sifting+through+the+surfeit+of+neuroinflammation+tracers&rft.jtitle=Journal+of+cerebral+blood+flow+and+metabolism&rft.au=Cumming%2C+Paul&rft.au=Burgher%2C+Bjorn&rft.au=Patkar%2C+Omkar&rft.au=Breakspear%2C+Michael&rft.date=2018-02-01&rft.pub=SAGE+Publications&rft.issn=0271-678X&rft.eissn=1559-7016&rft.volume=38&rft.issue=2&rft.spage=204&rft.epage=224&rft_id=info:doi/10.1177%2F0271678X17748786&rft_id=info%3Apmid%2F29256293&rft.externalDocID=PMC5951023 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-678X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-678X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-678X&client=summon |